{
  "claim_id": "claim_002",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "document": "CDC_Influenza_vaccines",
  "supporting_evidence": [],
  "image_supporting_evidence": [],
  "evidence_summary": {
    "total_text_evidence_found": 0,
    "total_image_evidence_found": 0,
    "total_evidence_found": 0,
    "coverage": "complete",
    "missing_aspects": []
  },
  "metadata": {
    "extraction_stats": {
      "total_verified": 0
    },
    "rejected_count": 0
  }
}